Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

If the study results were positive then the company should have released a press release stating that was the case and that the commercial potential for MANF would be the focus of the Med Forum presentation.

To delay the results for almost three weeks make no sense unless the results were borderline. The share price will get hammered considering the recent momentum run-up which was due to a large part due that the anticipated study results would be released this week.

The worse thing for a penny stock is to lose momentum.

Average down when it hits .035 and hope for a pre forum bounce.